8 February 2023 11:40 p.m. All figures in US dollars. The profits announced by STERIS plc in the third quarter were lower than the Refinitiv mean estimate of profits. The company reported profits of $2.02 per share, 10 cents lower than the same quarter last year when the company reported EPS of $2.12. Profits of $2.19 per share were anticipated by the six analysts providing estimates for the quarter. Wall Street expected results to range from $2.17 to $2.26 per share, with a forecasted mean of $2.19 per share. The company reported revenue of $1.22 billion, which is lower than the estimated $1.27 billion. RECOMMENDATIONS * The consensus recommendation for the company is "Buy". * The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "Buy". FORECAST CHANGES * Six analysts are currently providing Refinitiv with estimates. * In the last week there have been no earnings estimate revisions by analysts covering the company. There was no change to the number of estimates. YEAR OVER YEAR * The company reported an increase in revenue to $1.22 billion from $1.21 billion in the same quarter last year. * Previous quarterly performance (using earnings preferred measure) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET, MISSED Sep. 30 2022 1.98 1.99 Beat Jun. 30 2022 1.92 1.90 Missed Mar. 31 2022 2.02 2.04 Beat Dec. 31 2021 1.96 2.12 Beat This summary was machine generated from Refinitiv data February 8 at 11:40 p.m.
